Literature DB >> 25916109

[MiR-128, a key regulator of oncogenic properties].

D Q Huang, P Guo, N H Lv, L Y Luo.   

Abstract

MicroRNAs (miRNA) are small noncoding RNAs that are critical regulators of gene function. In the recent years, miRNAs have been increasingly noted for their capacity to regulate key malignant properties of tumor cells. MicroRNA-128 (miR-128) is a brain-enriched miRNA that is normally involved in the development of the nervous system and in the maintenance of neural physiological functions. In tumorcells, miR-128 expression is dysregulated through a variety of genetic and epigenetic events. Dysregulation: of miR-128 has profound effects on tumorigenesis and maintenance of tumor cells through alterations in cellular proliferation, differentiation, metabolism, and apoptosis. This article will review the latest advances in our understanding of miR-128, specifically in the context of clinical and fundamental cancer biology. Further characterization of miR-128 will likely identify its new roles in cancer biology. The use of miR-128 as a diagnostic and/or therapeutic tool may result in improvements in diagnosis, prognosis, and treatment of numerous cancers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25916109     DOI: 10.7868/s0026898415010061

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  4 in total

1.  Integrative Analyses of miRNA-mRNA Interactions Reveal let-7b, miR-128 and MAPK Pathway Involvement in Muscle Mass Loss in Sex-Linked Dwarf Chickens.

Authors:  Wen Luo; Shumao Lin; Guihuan Li; Qinghua Nie; Xiquan Zhang
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

2.  Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases

Authors:  Roxan E Shafik; Nahed Abd El Wahab; Salwa A Senoun; Emad Ebeid; Maha A El Taweel
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

3.  Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.

Authors:  Heqin Zhan; Feng Huang; Qian Niu; Mingli Jiao; Xumeng Han; Kaina Zhang; WenZhuo Ma; Shan Mi; Shiyu Guo; Zhenghang Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-10-04       Impact factor: 6.543

Review 4.  Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer.

Authors:  Tzitzijanik Madrigal; Jesús Hernández-Monge; Luis A Herrera; Claudia Haydée González-De la Rosa; Guadalupe Domínguez-Gómez; Myrna Candelaria; Fernando Luna-Maldonado; Karla G Calderón González; José Díaz-Chávez
Journal:  Front Cell Dev Biol       Date:  2021-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.